The combination of trastuzumab and vinorelbine as a atractive regimen in overexpressing metastatic breast cancer patients

3212 Background: Trastuzumab (T) and vinorelbine (V) combination has previously shown as a interesting regimen for Her-2 positive metastatic breast cancer (mbc) patients(pts). It is retrospective a...